Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_148

CAPS Consortium International Consensus for pancreatic cancer surveillance in high-risk individuals. Gut 2020;69(1):7–17. CDKN2A surveillance protocol — annual EUS + MRI/MRCP from age 40–50 in many centres; incidentaloma rate ~30%. [Tasks: 14] Tier: 1 Grade: A Retrieved: 2026-05-07

Evidence grade
A
Tier
1
Cited by tasks
14
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_148/findings.md (research corpus). This page is a short context summary — not individualised medical advice.